Oncology Clinical Pharmacist
START Center for Cancer Research
Oncology Clinical Pharmacist
START Center for Cancer Research
Phase 1 cancer trials with genomic profiling
The START Center for Cancer Research (“START”) is the world’s largest early phase site network, fully dedicated to oncology clinical research. Throughout our history, START has provided hope to cancer patients in global community practices by offering "Hope Through Access” to cutting edge trials throughout the United States and Europe.
We are seeking a Clinical Pharmacist, Investigational Drug Section. The Clinical Pharmacist, Investigational Drug Section (IDS) is responsible for all facets of medication order verification, dispensing and documentation process for investigational drugs, conventional chemotherapy and supportive care medications provided by the IDS. The pharmacist may be involved in the provision of pharmaceutical care including assisting with patient interviews, maintenance of current medication lists, providing patient medication education, providing drug information to the healthcare team and patients. The pharmacist will practice with a high degree of autonomy, guided by IDS SOPs and quality assurance verification guidelines. This role is responsible for the daily supervision of staff assigned to medication preparation, dispensing, and operation of the IDS in accordance with all applicable rules and regulations.
Work Schedule: Monday - Friday 8:00 a.m. - 5:00 p.m.
Location: START Dallas Fort Worth: 900 W Magnolia Ave, Suite 200, Fort Worth, TX 76104
Essential Responsibilities:
Education & Experience:
Preferred Education and Experience:
Physical and Travel Requirements:
Best-in-Class Benefits and Perks
We value the time, talent, and dedication our employees bring to START. Our commitment to your well-being and growth is reflected in a competitive compensation package—based on experience—along with comprehensive benefits designed to support you both personally and professionally:
More About START
START clinical trial sites have conducted more than 1,000 early-phase clinical trials, including dozens of therapies that were approved by the FDA or EMA. START represents the world’s largest roster of early-phase principal investigators across its Network of clinical trial sites.
Learn more at STARTresearch.com.
Ready to be part of a team changing the future of cancer treatment?
Join us in our mission to conquer cancer, one clinical trial at a time. Your expertise and dedication can help us bring hope and healing to patients worldwide. Please submit your application online.
We are an equal opportunity employer that welcomes and encourages diversity in the workplace. We do not discriminate on the basis of race, color, religion, marital status, age, national origin, ancestry, physical or mental disability, medical condition, pregnancy, genetic information, gender, sexual orientation, gender identity or expression, veteran status, or any other status protected under federal, state, or local law.
Phase 1 cancer trials with genomic profiling
START Center for Cancer Research runs Phase 1 clinical trials for novel anti-cancer therapies through a network of research sites in the United States, Spain, Portugal, and Ireland. It connects patients with early-stage trials, supported by genetic tumor profiling, multi-disciplinary care, and state-of-the-art treatment technology, to test new drugs before they reach broader use. The center distinguishes itself by its large, community-based trial network with 40+ principal investigators and a track record of conducting over 1,500 early-phase trials, including 50 therapies that later gained FDA/EMA approval. Its goal is to speed the translation of clinical research into available treatments and to expand access to innovative options for patients and physicians worldwide.
Explore more opportunities at START Center for Cancer Research